Followers | 11 |
Posts | 3875 |
Boards Moderated | 0 |
Alias Born | 07/19/2021 |
Sunday, April 21, 2024 11:00:43 AM
it's about keeping them honest and that doesn't require wishing anything. due diligence removes any need for wishing away.
when you do the due diligence, research leadership background and experience, then seeing the proof in the pudding with filings, it's a no brainer finding the truth about a company and being able to see through tweets and press releases.
the best days the company enjoyed with fake PROMOS are now over. the cat is out of the bag. nobody will lend this company a dime any longer. no more money to be stolen, any longer, through PROMO pump and dump shows.
so, the only strategy left now seems to be go quiet, by not posting any tweets, not file with the SEC on time, to allow the wizard to plot and plan his own exit strategy while leaving the common shareholders, first, in the dark and then the dust.
only real obvious tea leaf is finding yourself in a potential difficult position (under a microscope) and need to make changes to previous and/or current filing(s). there's always a real reason (not positive) when a company cannot file an annual 10-K after it has already filed 3 of 4 10-Qs for the same annual period.
thus, the reason for Foxess only showing Snpw, as a partner, in one old back door link and not its new U.S. websites pages. see link below
from main corporate website homepage and no more visible Snpw global partner link in the drop down: https://www.fox-ess.com/
if you know anything about websites, there is only a Snpw global partner back door link from old website being the one drugmanrx needs to rely on now. LOL
my opinions are just that
good luck
Recent SNPW News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 09:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:36 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/23/2023 09:15:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/13/2023 09:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:06:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM